Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Translational Oncology|August 29, 2016
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma CellsAlicia M Waters, Laura L Stafman, Evan F Garner, et al.Plos One|April 11, 2019
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cellsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.Translational Oncology|November 10, 2018
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in HepatoblastomaLaura L Stafman, Adele P Williams, Evan F Garner, et al.Translational Oncology|October 5, 2018
Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor GrowthAdele P Williams, Evan F Garner, Alicia M Waters, et al.Journal of Pediatric Surgery|November 5, 2018
Corruption of neuroblastoma patient derived xenografts with human T cell lymphomaAdele P Williams, Jerry E Stewart, Laura L Stafman, et al.Frontiers in Bioscience (Elite Edition)|January 4, 2011
MYCN, neuroblastoma and focal adhesion kinase (FAK)Elizabeth A BeierleJournal of Pediatric Surgery|March 23, 2019
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survivalLaura L Stafman, Mary G Waldrop, Adele P Williams, et al.Scientific Reports|May 4, 2018
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived XenograftsEvan F Garner, Adele P Williams, Laura L Stafman, et al.Translational Oncology|October 3, 2020
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Laura L Stafman, et al.Pageof 17